116 related articles for article (PubMed ID: 2450171)
1. Myelin basic protein is an endogenous inhibitor of the high-affinity cannabinoid binding site in brain.
Nye JS; Voglmaier S; Martenson RE; Snyder SH
J Neurochem; 1988 Apr; 50(4):1170-8. PubMed ID: 2450171
[TBL] [Abstract][Full Text] [Related]
2. High-affinity cannabinoid binding sites in brain membranes labeled with [3H]-5'-trimethylammonium delta 8-tetrahydrocannabinol.
Nye JS; Seltzman HH; Pitt CG; Snyder SH
J Pharmacol Exp Ther; 1985 Sep; 234(3):784-91. PubMed ID: 2993595
[TBL] [Abstract][Full Text] [Related]
3. High-affinity cannabinoid binding site: regulation by ions, ascorbic acid, and nucleotides.
Nye JS; Snowman AM; Voglmaier S; Snyder SH
J Neurochem; 1989 Jun; 52(6):1892-7. PubMed ID: 2723643
[TBL] [Abstract][Full Text] [Related]
4. Myelin basic protein is affected by reduced synthesis of myelin proteolipid protein in the jimpy mouse.
Fannon AM; Moscarello MA
Biochem J; 1990 May; 268(1):105-10. PubMed ID: 1693071
[TBL] [Abstract][Full Text] [Related]
5. Study of expression of myelin basic proteins (MBPs) in developing rat brain using a novel antibody reacting with four major isoforms of MBP.
Akiyama K; Ichinose S; Omori A; Sakurai Y; Asou H
J Neurosci Res; 2002 Apr; 68(1):19-28. PubMed ID: 11933045
[TBL] [Abstract][Full Text] [Related]
6. ADP-ribosylation of myelin basic protein by cholera toxin.
Enomoto K; Asakawa T
Biochim Biophys Acta; 1990 Dec; 1036(3):188-92. PubMed ID: 1701661
[TBL] [Abstract][Full Text] [Related]
7. Cerebrocystatin suppresses degradation of myelin basic protein by purified brain cysteine proteinase.
Kopitar M; Stern F; Marks N
Biochem Biophys Res Commun; 1983 May; 112(3):1000-6. PubMed ID: 6189487
[TBL] [Abstract][Full Text] [Related]
8. Encephalitogenic activity of the small form of mouse myelin basic protein in the SJL/J mouse.
Chou CH; Shapira R; Fritz RB
J Immunol; 1983 May; 130(5):2183-6. PubMed ID: 6187842
[TBL] [Abstract][Full Text] [Related]
9. Studies on NG-methylarginine derivatives in myelin basic protein from developing and mutant mouse brain.
Rawal N; Lee YJ; Paik WK; Kim S
Biochem J; 1992 Nov; 287 ( Pt 3)(Pt 3):929-35. PubMed ID: 1280107
[TBL] [Abstract][Full Text] [Related]
10. Immunochemical cross-reactivity between intact purified myelin basic protein (MBP) and the synthetic encephalitogenic peptide S49.
Lazarus KJ; Hashim GA; Paterson PY; Day ED
Neurochem Res; 1984 Sep; 9(9):1295-308. PubMed ID: 6209588
[TBL] [Abstract][Full Text] [Related]
11. Chronic cannabinoid administration alters cannabinoid receptor binding in rat brain: a quantitative autoradiographic study.
Oviedo A; Glowa J; Herkenham M
Brain Res; 1993 Jul; 616(1-2):293-302. PubMed ID: 8395305
[TBL] [Abstract][Full Text] [Related]
12. Characterisation and visualisation of [3H]dermorphin binding to mu opioid receptors in the rat brain. Combined high selectivity and affinity in a natural peptide agonist for the morphine (mu) receptor.
Amiche M; Sagan S; Mor A; Pelaprat D; Rostene W; Delfour A; Nicolas P
Eur J Biochem; 1990 May; 189(3):625-35. PubMed ID: 2161761
[TBL] [Abstract][Full Text] [Related]
13. Studies on myelin-basic-protein methylation during mouse brain development.
Chanderkar LP; Paik WK; Kim S
Biochem J; 1986 Dec; 240(2):471-9. PubMed ID: 2434074
[TBL] [Abstract][Full Text] [Related]
14. Cleavage of myelin basic protein by neutral protease activity of human white matter and myelin.
Berlet HH; Ilzenhöfer H; Schulz G
J Neurochem; 1984 Sep; 43(3):627-33. PubMed ID: 6205122
[TBL] [Abstract][Full Text] [Related]
15. Use of protein-bearing nitrocellulose as immunogen for in vitro production of monoclonal antibodies: application to myelin basic protein electrophoretically separated from a complex brain protein mixture.
Sheng HZ; Hoogenraad J; Carnegie PR; Bernard CC
Immunol Lett; 1987 Oct; 16(1):75-81. PubMed ID: 2448235
[TBL] [Abstract][Full Text] [Related]
16. Differential racemization of aspartate and serine in human myelin basic protein.
Shapira R; Chou CH
Biochem Biophys Res Commun; 1987 Aug; 146(3):1342-9. PubMed ID: 2441703
[TBL] [Abstract][Full Text] [Related]
17. Synthetic myelin basic protein peptide analogs are specific inhibitors of phospholipid/calcium-dependent protein kinase (protein kinase C).
Su HD; Kemp BE; Turner RS; Kuo JF
Biochem Biophys Res Commun; 1986 Jan; 134(1):78-84. PubMed ID: 2418828
[TBL] [Abstract][Full Text] [Related]
18. Detection of various forms of brain myelin basic protein in vertebrates by electroimmunoblotting.
Kerlero De Rosbo N; Carnegie PR; Bernard CC; Linthicum DS
Neurochem Res; 1984 Oct; 9(10):1359-69. PubMed ID: 6083464
[TBL] [Abstract][Full Text] [Related]
19. Parital characterization of the rat anti-encephalitogenic protein (RSCP).
MacPherson CF; Armstrong H
J Immunol; 1976 Feb; 116(2):398-402. PubMed ID: 55440
[TBL] [Abstract][Full Text] [Related]
20. Lipid-bound, native-like, myelin basic protein. Batch-wise preparation and perspectives for use in demyelinating diseases.
Riccio P; Liuzzi GM; Quagliariello E
Mol Chem Neuropathol; 1990 Dec; 13(3):185-94. PubMed ID: 1712204
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
